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Abstract Late onset aura (LOA) is usually considered
benign but raises diagnostic uncertainties. We compared
individuals with LOA ([45 years of age at aura onset) with
those of early onset (EOA) in clinical features, vascular
risk factors and imaging, in a retrospective study design
including patients with migraine aura and age[44 years at
ﬁrst visit. In 77 cases (51 EOA and 26 LOA), no differ-
ences were found in gender distribution, family or personal
history of migraine without aura, type of aura symptoms or
imaging ﬁndings. LOA patients’ were more likely to not
fulﬁl all ICHD-II aura criteria and to lack headache. This
data suggest that LOA and EOA are overall identical but
there are differences in presentation that deserve a better
characterization by a prospective study.
Introduction
‘‘Late life migraine accompaniments’’ were ﬁrst described
by Fisher in individuals whose aura began after the 40th
decade [1]. Although there is an evidence supporting the
benign nature of this syndrome [2], it raises diagnostic
doubts, particularly because subjects with aura are more
likely to suffer silent brain infarcts [3], epilepsy [4] and all-
cause mortality, including cardiovascular disease [5]. Thus,
it is relevant to know if auras of late onset have any par-
ticular features or complications compared to their typical
counterparts.
Methods
We conducted a retrospective analysis of the last 100
patients observed in a headache outpatient clinic with
(a) age C45 years at ﬁrst visit and, (b) the clinical diag-
nosis of migraine aura. All types of aura were included,
namely auras without headache, with non-typical or typical
migraine headache or persistent auras, as deﬁned by the
ICHD-II [6].
Patients were divided into two groups: early onset aura
(EOA), if aura began before their 45th anniversary and late
onset aura (LOA) if later than that. This age cut-off was
mentioned by Fisher [1] and it represents a turning point in
migraine epidemiology, with a decline in prevalence and
incidence [7]. Besides, it has been used as a cut-off point
for stroke in young adults [8]. To ensure that both groups
were comparable in age, we only included subjects with a
minimum age of 45 at ﬁrst visit, independently from their
follow-up time in clinic or if they had migraine beginning
years before. However, to avoid recall bias, data collected
concerned only symptoms recorded at ﬁrst and follow up
consultations and not their past symptoms.
Clinical evaluation followed a semi-structured inter-
view, neurological examination and record of diagnosis
and exams performed. Data collected from records com-
prised: age at ﬁrst consultation and of aura onset, gender,
type of aura symptoms, clinical diagnosis, ICHD-II criteria
[6], frequency of aura attacks including what we designated
as ‘‘aura status’’ (i.e., the recurrence of aura episodes in a
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vascular risk factors, neurological co-morbidities (namely
stroke, epilepsy, episodes of vertigo, depressive symptoms
and sleep complaints) and results of neuroimaging and
EEG. Comparisons were calculated using non-parametric
tests for categorical variables and independent samples
t tests for continuous variables (signiﬁcance level of
a = 0.05). The project was approved by the Ethics Com-
mittee of the Faculty of Medicine.
Results
In 100 identiﬁed cases, ﬁve did not fulﬁl inclusion criteria
and records were unavailable in 18, producing a sample of
77 case records. Main ﬁndings are summarized in Table 1.
No differences were found in gender distribution, type of
aura symptoms, and frequency of migraine without aura or
family history of migraine. Patients with LOA were more
likely to have attacks of aura without typical migraine
Table 1 Population characteristics and clinical features by study group
Total Early onset
aura (EOA)
Late onset
aura (LOA)
Statistics: Chi-Square,
Fisher exact test or t test
N 77 51 26
Gender (F:M) 59:18 40:11 19:7 n.s.
Age at consultation (mean ± SD) 53.6 ± 7.8 50.5 ± 5.6 59.6 ± 8.2 t =- 5.1, p\0.001
Age at aura onset (mean ± SD) 36.6 ± 19.1 25 ± 12.5 55.2 ± 11.6 t =- 9.8, p\0.001
Clinical diagnosis (AWMH:AwoMtH) 55:22 45:6 10:16 v
2(1) = 20.9, p\0.001
Attacks of MWoA (Y:N) 48:29 31:20 17:9 n.s.
Attacks of AWnMH (Y:N) 11:66 9: 42 2:24 n.s.
Attacks of AWoMH (Y:N) 33:44 15:36 18:8 v
2(1) = 11.1, p = 0.001
‘‘Aura status’’ (Y:N) 8:68 4:47 4:21 n.s.
Aura symptoms
Visual (Y:N) 74:3 50:1 24:2 n.s.
Only negative 11/65 (16.9%) 7/42 (16.7%) 4/23 (17.4%) n.s.
Only positive 15/65 (23%) 10/42 (23.8%) 5/23 (21.7%)
Positive and negative symptoms 39/65 (60%) 25/42 (59.5%) 14/23 (60.9%)
Somatosensory (Y:N) 19:58 14:37 5:21 n.s.
Aphasia (Y:N) 21:56 12:39 9:17 n.s.
Other (Y:N) 7:70 5:46 2:24 n.s.
Multiple (Y:N) 22:54 13:38 9:16 n.s.
Aura fulﬁlling ICHD-II criteria (Y:N) 49:11 32 (91.4%):3 17 (68%):8 Fisher exact test, p\0.05
Family history of migraine (Y:N) 43:24 28:15 15:9 n.s.
Follow-up time (years) 2.6 ± 4 2.3 ± 3.7 3.4 ± 4.5 p = n.s.
Co-morbidities
Hypertension (Y:N) 24 (32.9%):49 11 (23.4%):36 13 (50%):13 v
2(1) = 5.36, p\0.02
Diabetes mellitus (Y:N) 1:72 1:47 0:25 n.s.
Other cardiovascular disease (Y:N) 6:61 4:39 2:22 n.s.
Depressive symptoms 25/66 (37.8%) 13/44 (29.5%) 12/22 (54.5%) v
2(1) = 3.89, p\0.05
Sleep complaints (Y:N) 17:49 11:33 6:16 n.s.
Seizures (Y:N) 4:51 4:38 0:13 Fisher exact test, p = n.s.
Stroke (Y:N) 2:68 2:46 0:22 n.s.
Vertigo (Y:N) 18:38 10:24 8:14 n.s.
Normal imaging (Y:N) 44:18 29:13 15:5 n.s.
WMH (Y:N) 8:54 5:37 3:17 n.s.
Vascular lesions (Y:N) 6:56 4:38 2:18 n.s.
Non-vascular lesions (Y:N) 9:53 6:36 3:17 n.s.
Normal EEG (Y:N) 14:5 8:5 6:0 n.s.
F females, M males, AWMH typical aura with migraine headache, AWnMH typical aura with non-migraine headache, AwoMH typical aura
without migraine headache, AwoMtH aura without migraine-type headache (AWnMH ? AwoMH), MWoA migraine without aura, WMH white
matter hyperintensities
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123headache compared to EOA. Aura’s symptoms were
mostly visual. Aura duration, divided in \20, 20–60 and
[60 min, was identical in both groups (respectively 23.3,
56.7 and 20% in EOA and 47.8, 39.1 and 13% in LOA,
p = n.s.). Monthly frequency of aura attacks was also
similar (3.4 ± 6.6 in EOA and 3.8 ± 6.3 in LOA,
p = n.s.), as was the occurrence of ‘‘aura status’’, as pre-
viously deﬁned. There were more cases in LOA with the
diagnosis of probable migraine aura (ICHD-II) than among
EOA. Reasons were the presence of a single aura episode
(N = 5) and a longer duration[60 min (N = 3).
Most patients (78%) had brain imaging and the majority
were normal, with no group differences in the type of
abnormalities found (white matter hyperintensities, vascu-
lar or non-vascular lesions). Although two EOA cases had
abnormalities that may underlie symptomatic headache
(tumour and arteriovenous malformation), those had no
temporal relation with migraine, making causality unlikely.
Discussion
The late onset of migraine aura is often a source of concern
and clinicians must consider other causes of transient
neurological symptoms such as TIAs, epilepsy or oph-
thalmological disorders.
The present study aimed to understand if patients with
LOA shared clinical features, risk factors and co-morbid-
ities with EOA. The results were overall identical, sug-
gesting that we stand before a single condition, i.e.
migraine. In fact, the two groups had a predominance of
females and reported identical family and personal history
of migraine headaches, thus, sharing the same gender and
genetic susceptibility. Furthermore, there were no differ-
ences in imaging ﬁndings or neurological co-morbidities
except that LOA patients were more likely to have
hypertension and depressive symptoms, which may simply
result from their higher age, hence not allowing inferences
of causality. Although sleep disturbances may trigger
attacks, they were similar in both groups.
Concerning the clinical diagnosis, LOA patients often
presented with isolated auras, auras with atypical headache,
or only fulﬁlled ICHD-II criteria of probable migraine with
aura, whereas EOA patients presented mainly aura with
migraine headache. This is in accordance with the studies
demonstrating phenotype changes in migraine in lifetime
with decreasing headache and associated symptoms [7].
Identical ﬁndings were reported in the Framingham study
[2] (only 19% of participants fulﬁlled ICHD-II criteria) and
in Fisher’s study [1] (27% subjects had a single attack and
27% prolonged attacks, similarly to our study).
Aura characteristics, including type, duration and fre-
quency, were similar in both groups. An analysis of the
same data with an age cut-off at 65 years yielded identical
results, suggesting an age-related trend in migraine phe-
notypic presentation with less headache and more aura
phenomena, which so far has not been explained.
We acknowledge limitations to this study, the most
important being its retrospective design. Lack of systematic
record of all variables produces biases favouring positive
ﬁndings. In addition, the inclusion of patients older than
44 years at ﬁrst visit may bias subjects towards those with
late migraine aggravation, but this is balanced by the
presence of a group matched by ‘‘late’’ consultation.
In summary, this study supports the essentially benign
nature of LOA but also underlines some of its particular
features. Since it does not allow ﬁrm conclusions, we
highlight the need to conduct a further study with a lon-
gitudinal prospective design.
Acknowledgments The authors thank Fa ´tima Nascimento and
Andre ´ Correia of the Department of Medical Records, Hospital Santa
Maria, CHLN for their assistance in obtaining patients ﬁles.
Conﬂict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Fisher C (1986) Late-life migraine accompaniments—further
experience. Stroke 17:1033–1042
2. Wijman CAC, Wolf PA, Kase CS, Kelly-Hayes M, Beiser AS
(1998) Migrainous visual accompaniments are not rare in late life:
the Framingham Study. Stroke 29:1539
3. KurthT,MohamedS,MaillardP,ZhuY-C,ChabriatH,MazoyerB,
BousserM-G,DufouilC,TzourioC(2011)Headache,migraine,and
structuralbrainlesionsandfunction:populationbasedepidemiology
ofvascularageing-MRIstudy.BMJ342:c7357–c7357.doi:10.1136/
bmj.c7357
4. Le H, Tfelt-Hansen P, Russell MB, Skytthe A, Kyvik KO, Olesen J
(2011) Co-morbidity of migraine with somatic disease in a large
population-based study. Cephalalgia 31:43–64. doi:10.1177/03331
02410373159
5. Gudmundsson LS, Scher AI, Aspelund T, Eliasson JH, Johannsson
M, Thorgeirsson G, Launer L, Gudnason V (2010) Migraine with
aura and risk of cardiovascular and all cause mortality in men and
women: prospective cohort study. BMJ 341:c3966. doi:10.1136/
bmj.c3966
6. Headache Classiﬁcation Subcommittee of the International Head-
ache Society (2008) The international classiﬁcation of headache
disorders: accurate diagnosis of orofacial pain? Cephalalgia Int
J Headache 28:752–762. doi:10.1111/j.1468-2982.2008.01586.x
7. Bigal ME, Liberman JN, Lipton RB (2006) Age-dependent prev-
alence and clinical features of migraine. Neurology 67:246–251.
doi:10.1212/01.wnl.0000225186.76323.69
8. Bigi S, Fischer U, Wehrli E, Mattle HP, Boltshauser E, Bu ¨rki S,
JeannetP-Y,FlussJ,WeberP,NedeltchevK,El-KoussyM,Steinlin
M,ArnoldM(2011)Acuteischemicstrokeinchildrenversusyoung
adults. Ann Neurol 70:245–254. doi:10.1002/ana.22427
J Headache Pain (2012) 13:243–245 245
123